Nautilus Biotechnology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Nautilus Biotechnology, Inc. (NAUT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $3.74 per share as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-07-28
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.74.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.93.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.00.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $4.04.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $3.74 10-Q · filed 2026-07-28 |
| 2026-03-31 | $3.93 10-Q · filed 2026-04-28 |
| 2025-12-31 | $4.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $4.04 10-Q · filed 2025-10-28 |
| 2025-06-30 | $3.91 10-Q · filed 2025-07-31 |
| 2025-03-31 | $3.95 10-Q · filed 2025-04-29 |
| 2024-12-31 | $4.02 10-K · filed 2025-02-27 |
| 2024-09-30 | $3.87 10-Q · filed 2024-10-29 |
| 2024-06-30 | $3.83 10-Q · filed 2024-07-30 |
| 2024-03-31 | $3.85 10-Q · filed 2024-04-30 |
| 2023-12-31 | $3.90 10-K · filed 2024-02-28 |
| 2023-09-30 | $3.88 10-Q · filed 2023-10-31 |
| 2023-06-30 | $3.87 10-Q · filed 2023-08-02 |
| 2023-03-31 | $3.87 10-Q · filed 2023-05-02 |
| 2022-12-31 | $3.85 10-K · filed 2023-02-23 |
| 2022-09-30 | $3.73 10-Q · filed 2022-11-01 |
| 2022-06-30 | $3.59 10-Q · filed 2022-08-02 |
| 2022-03-31 | $3.01 10-Q · filed 2022-05-03 |
| 2021-12-31 | $0.88 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.66 10-Q · filed 2021-11-02 |
| 2021-06-30 | $0.46 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |